Pharmaceutical kit comprising midodrine as an active drug...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/20 (2006.01) A61K 9/00 (2006.01) A61K 9/127 (2006.01) A61K 9/24 (2006.01) A61K 9/28 (2006.01) A61K 9/48 (2006.01) A61K 9/50 (2006.01) A61K 9/70 (2006.01) A61K 31/137 (2006.01) A61K 31/165 (2006.01) A61K 47/18 (2006.01)

Patent

CA 2403958

Novel pharmaceutical kit comprising controlled release pharmaceutical compositions for oral use containing midodrine and/or its active metabolite desglymidodrine and a relatively fast onset composition. The controlled release compositions are designed to release midodrine and/or desglymidodrine after oral intake in a manner which enables absorption to take place in the gastrointestinal tract so that a relatively fast peak plasma concentration of the active metabolite desglymidodrine is obtained followed by a prolonged and relatively constant plasma concentration of desglymidodrine. Also disclosed is a method for treated orthostatic hypotention and/or urinary incontinence, the method comprising administration to a patient in need thereof of an effective amount of midodrine and/or desglymidodrine in a kit according to the invention.

L'invention concerne une nouvelle composition pharmaceutique comportant des compositions préparations pharmaceutiques à diffusion contrôlée pour une utilisation orale contenant de la midodrine et/ou son métabolite actif le desglymidodrine et une préparation à effet retard relativement rapide. Les préparations à diffusion contrôlée sont conçues pour diffuser la midodrine et/ou le desglymidodrine après ingestion orale, d'une façon telle qu'elle permet à l'absorption de se produire dans le tractus gastro-intestinal, de manière à ce qu'un pic de concentration de plasma du métabolite actif desglymidodrine soit obtenu relativement rapidement suite à une concentration de plasma de desglymidodrine relativement constante et prolongée. L'invention concerne également un procédé de traitement de l'hypotension orthostatique et/ou de l'incontinence urinaire. Ce procédé comporte l'administration à un patient souffrant de ces troubles d'une quantité efficace de midodrine et/ou de desglymidodrine dans une composition conformément à la présente invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical kit comprising midodrine as an active drug... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical kit comprising midodrine as an active drug..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical kit comprising midodrine as an active drug... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1723016

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.